Mazdutide
A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
Innovent · Phase 2 · Active, not recruiting · Enrollment 141
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| IBI362 4.0mg | Obesity or overweight | 4.0mg | n/r | n/r | n/r |
| placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| IBI362 6.0mg | Obesity or overweight | 6.0mg | n/r | n/r | n/r |